The CDC says other antibiotics should be considered for prevention among close contacts in areas where ciprofloxacin-resistant cases have been reported.
Nirsevimab effectiveness was greater than 70% in infants under 9 months.
The authors acknowledge that the findings may have been influenced by confounding factors and bias.
As small clusters continue, the CDC notes that only 1 in 4 eligible people have received both mpox vaccine doses.
The patient is the brother of a boy who recently died from an H5N1 infection.
COVID-19 was associated with a 30% increased subsequent risk of a first cardiovascular event.
So far, the cases have been detected in 3 South African provinces and aren't fueling a resurgence in cases.
A population-based study in Shanghai finds COPD patients are nearly 8 times more likely to use antibiotics than the general population.
Long COVID was not associated with any one trimester of pregnancy.
During the 6-years analysis, maternal infections rose 222%.
The NIH is investing $515 million more in its long COVID research program.
The woman had bought a duck at a live market, and meat samples were positive for H10N5.
Chlorination wasn't required for the city's water system, and city officials are developing a disinfection plan and considering their next steps.
A team of researchers from Harvard is developing synthetic antibiotics enhanced to overcome resistance mechanisms.
New data from a study in low- and middle-income countries shows a dose of azithromycin before planned vaginal delivery saves more than $32,000 per 100,000 pregnancies.
The vaccine campaign targets 610,000 people in South Sudan's Western Equatoria state.
Sensitivity was 99% for all patients and 100% in the people affected by HIV.
Girls (43%) were more likely than boys (35%) to have received one or more HPV vaccine doses.
At least half of US adults hospitalized with uncomplicated community-acquired pneumonia in 2020 received 7 days or more of antibiotics.
MERS-CoV antibody reactivity was identified in 7 of 48 camel-slaughterhouse workers (15%).
Nationally, 6.4% of US adults reported ever having experienced long COVID
The results of a phase 3 trial suggest cefepime-taniborbactam is a treatment option for patients with complicated UTIs caused by difficult-to-treat, gram-negative bacteria.
The updated guidelines will be released later this year.
Having tools to identify outbreaks early is crucial for containing outbreaks for both dangerous pathogens.
Treatment shortened symptoms by a day and also reduced viral loads.
